Editorial: On the cusp of rational CHO cell engineering

Biotechnology Journal

Volumn 10, Issue 7, 2015, Pages 929-930

  Nielsen, Lars ^a   Borth, Nicole ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BATCH PROCESS; BIOINFORMATICS; BIOREACTOR; CELL ENGINEERING; CELL FUNCTION; CELL GROWTH; CHINESE HAMSTER; CHO CELL LINE; CONTINUOUS PROCESS; EDITORIAL; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; HUMAN; MAMMAL CELL; METABOLIC ENGINEERING; PRIORITY JOURNAL; STABLE EXPRESSION; SYNTHETIC BIOLOGY; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL THERAPY; CRICETULUS; GENOMICS;

MAMMALIA;

ANIMALS; CELL ENGINEERING; CELL- AND TISSUE-BASED THERAPY; CHO CELLS; CRICETULUS; GENOMICS; HUMANS;

EID: 84935472850     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201500375     Document Type: Editorial

References (13)

1. Kremkow, B. G., Baik, J. Y., MacDonald, M. L., Lee, K. H., CHOgenome.org 2.0: Genome resources and website updates. Biotechnol. J. 2015, 10, 931-938.
2. Gutierrez, J. M., Lewis, N. E., Optimizing eukaryotic cell hosts for protein production through systems biotechnology and genome-scale modeling. Biotechnol. J. 2015, 10, 939-949.
3. Monger, C., Kelly, P. S., Gallagher, C., Clynes, M. et al., Towards next generation CHO cell biology: Bioinformatics methods for RNA-Seq based expression profiling. Biotechnol. J. 2015, 10, 950-966.
4. Harraghy, N., Calabrese, D., Fisch, I., Girod, P-A. et al., Epigenetic regulatory elements: Recent advances in understanding their mode of action and use for recombinant protein production in mammalian cells. Biotechnol. J. 2015, 10, 967-978.
5. Lee, J. S., Grav, L. M., Lewis, N. E., Kildegaard, H. F., CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives. Biotechnol. J. 2015, 10, 979-994.
6. Kumar, S. R., Industrial production of clotting factors: Challenges of expression, and choice of host cells. Biotechnol. J. 2015, 10, 995-1004.
7. Xie, M., Fussenegger, M., Mammalian designer cells: Engineering principles and biomedical applications. Biotechnol. J. 2015, 10, 1005-1018.
8. Brown, A. J., Sweeney, B., Mainwaring, D. O., James, D. C., NF-κB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells. Biotechnol. J. 2015, 10, 1019-1028.
9. Kelly, P. S., Breen, L., Gallagher, C., Kelly, S. et al., Re-programming CHO cell metabolism using miR-23 tips the balance towards a highly productive phenotype. Biotechnol. J. 2015, 10, 1029-1040.
10. Dadehbeigi, N., Dickson, A. J., Chemical manipulation of the mTORC1 pathway in industrially relevant CHOK1 cells enhances production of therapeutic proteins. Biotechnol. J. 2015, 10, 1041-1050.
11. Villacrés, C., Tayi, V. S., Lattová, E., Perreault, H., Butler, M., Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture. Biotechnol. J. 2015, 10, 1051-1066.
12. Baik, J. Y., Dahodwala, H., Oduah, E., Talman, Lee et al., Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin. Biotechnol. J. 2015, 10, 1067-1081.
13. Kaas, C. S., Bolt, G., Hansen, J. J., Andersen, M. R., Kristensen, C., Deep sequencing reveals different compositions of mRNA transcribed from the F8 gene in a panel of FVIII-producing CHO cell lines. Biotechnol. J. 2015, 10, 1082-1089.